Photo by nci from unsplash
The 21‐gene recurrence score (RS) assay stratifies early‐stage, estrogen receptor–positive breast cancer by recurrence risk. Few studies have examined the ways in which physicians use the RS to recommend adjuvant… Click to show full abstract
The 21‐gene recurrence score (RS) assay stratifies early‐stage, estrogen receptor–positive breast cancer by recurrence risk. Few studies have examined the ways in which physicians use the RS to recommend adjuvant systemic chemotherapy or patients' experiences with testing and decision making.
Keywords:
recurrence score;
recurrence;
breast cancer;
early stage;
cancer;
score assay
Journal Title: Cancer
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Cancer
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!